Potential Application of ELAVL4 Real-Time Quantitative Reverse Transcription-PCR for Detection of Disseminated Neuroblastoma Cells
Open Access
- 1 March 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (3) , 438-445
Abstract
Background: Reliable detection of neuroblastoma cells in bone marrow (BM) is critical because BM involvement influences staging, risk assessment, and evaluation of therapeutic response in neuroblastoma patients. Standard cytomorphologic examination of BM aspirates is sensitive enough to detect single tumor cells. Consequently, more sensitive and specific detection methods are indispensable.Keywords
This publication has 34 references indexed in Scilit:
- Standardization of the Immunocytochemical Detection of Neuroblastoma Cells in Bone MarrowJournal of Histochemistry & Cytochemistry, 2005
- Detection of Disseminated Tumor Cells in NeuroblastomaThe American Journal of Pathology, 2003
- Flow cytometric immunophenotyping test for staging/monitoring neuroblastoma patientsCytometry, 2002
- Quantitative analysis of disseminated tumor cells in the bone marrow by automated fluorescence image analysisCytometry, 2000
- A New Sensitive and Specific Combination of CD81/CD56/CD45 Monoclonal Antibodies for Detecting Circulating Neuroblastoma Cells in Peripheral Blood Using Flow CytometryJournal of Pediatric Hematology/Oncology, 2000
- Flow cytometric analysis of peripheral blood and bone marrow for tumor cells in patients with neuroblastomaCancer, 1998
- Immunocytochemical detection of bone marrow‐invasive neuroblastoma cellsEuropean Journal of Haematology, 1994
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cellsBlood, 1994
- Gene-marking to trace origin of relapse after autologous bone-marrow transplantationThe Lancet, 1993
- International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.Journal of Clinical Oncology, 1988